Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502232 | SCV000594043 | uncertain significance | not specified | 2015-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002060107 | SCV002362709 | likely benign | not provided | 2024-10-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002527222 | SCV003690403 | likely benign | Inborn genetic diseases | 2022-09-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003902763 | SCV004726407 | likely benign | CEP135-related disorder | 2023-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |